Filing Details
- Accession Number:
- 0001209191-16-119740
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-13 09:30:15
- Reporting Period:
- 2016-05-12
- Filing Date:
- 2016-05-13
- Accepted Time:
- 2016-05-13 09:30:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1580849 | Robert Janssen | C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-12 | 1,000 | $15.12 | 1,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This price reflects the price for an open-market purchase of shares of Common Stock made by Robert Janssen on May 12, 2016.